Halozyme Therapeutics
HALO
#1700
Rank
A$17.92 B
Marketcap
A$157.91
Share price
0.53%
Change (1 day)
57.08%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): A$0.85 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.66 Billion. In 2025 the company made an earning of A$0.66 Billion a decrease over its 2024 earnings that were of A$0.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.85 B27.81%
2025 A$0.66 B-16.2%
2024 A$0.79 B59.94%
2023 A$0.49 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$88.1 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$46.1 Million-52.86%
2014 -A$97.79 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$76.59 Million169.94%
2011 -A$28.38 Million-63.44%
2010 -A$77.6 Million-7.19%
2009 -A$83.61 Million15.91%
2008 -A$72.13 Million83.89%
2007 -A$39.23 Million78.1%
2006 -A$22.03 Million16%
2005 -A$18.99 Million45.24%
2004 -A$13.08 Million682.42%
2003 -A$1.68 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.48 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.87 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.04 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.23 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.7 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$69.59 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA